The same technology could be extended to other types of proteins especially cancer markers such as Ca 15-3, 27, 125, bladder tumor antigen (BTA), carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), IL-10, as well as small molecules, as long as the required suitable aptamers are made available. This evidence concerns the gene AFP and cancer.